(Total Views: 111)
Posted On: 08/22/2022 8:40:56 AM
Post# of 47159

$CNCE News Article - Concert Pharmaceuticals Announces That Results From CTP-543 THRIVE?AA1 Phase 3 Trial in Patients With Alopecia Areata Selected for Late Breaking Presentation at EADV Congress https://marketwirenews.com/news-releases/conc...34109.html


My Twitter: WhyteStocks